Admescope is a contract research organisation (CRO) providing the pharmaceutical, biotechnology and veterinary industry with tailor made ADME-Tox research services.
Our service offering covers research services for peptides, biologics and small molecules and is widely spread over the whole ADME-Tox area. Admescope’s expertise for biologics research lies in protein structural characterisation, LC/MS and ELISA based quantification and pharmacokinetics. We also have an active R&D program for developing more services for biologics research.
Our continuous service development and ability to adapt customers’ in-house processes has a lot to do with our outstanding customer satisfaction rates. Performing beyond our customers’ needs and expectations is important to us, and therefore we invest a lot of time, money and effort into R&D.
The aim of our R&D activities is to strengthen our position in the market and further improve our expertise and skill set, as well as being able provide even more innovative and efficient ways to conduct studies and produce top quality data for our customers.
We are very committed to working closely with our customers through the whole study process. All of the studies include comprehensive study planning, tailoring the assay according to the compound(s) and interpretation of the results with recommendations for the future. Our careful individualistic approach enables us to provide high scientific and technical data quality that our customers’ can truly rely on in their decision making.
Currently Admescope serves customers in 25 countries on four continents. To learn more, please visit www.admescope.com.
There are two parts to the Festival of Biologics: three conferences covering Antibodies, Immunotherapy, Biosimilars and an exhibition featuring solutions for pharma and biotech.